| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |